The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety of bevacizumab in cancer patients with inflammatory bowel disease.
 
Ruth Gabriela Herrera Gomez
No Relationships to Disclose
 
Claire Gallois
No Relationships to Disclose
 
Marcel Adler
No Relationships to Disclose
 
David Malka
Honoraria - Amgen; Bayer; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Incyte; Merck Serono; MSD; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
David Planchard
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; MSD Oncology; Novartis; Pfizer; Roche
 
Barbara Pistilli
No Relationships to Disclose
 
Michel Ducreux
Honoraria - Lilly; Servier
Consulting or Advisory Role - Amgen; Celgene; Ipsen; Lilly; Merck Serono; Novartis; Roche; Servier
Speakers' Bureau - Bayer; Celgene; Ipsen; Merck KGaA; Roche
Research Funding - Pfizer; Roche
Travel, Accommodations, Expenses - Celgene; Ipsen; Merck Serono; Roche
Other Relationship - Sandoz (I)
 
Olivier Mir
Stock and Other Ownership Interests - Transgene
Honoraria - Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; GlaxoSmithKline; Lilly; Novartis; Pfizer; Roche; SERVIER; Vifor Pharma
Speakers' Bureau - Lilly; Roche
Travel, Accommodations, Expenses - Pfizer; PharmaMar; Roche